The LRIG family

Enigmatic regulators of growth factor receptor signaling

Catalina Simion, Maria Elvira Cedano-Prieto, Colleen A Sweeney

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The leucine-rich repeats and immunoglobulin-like domains (LRIG) family of transmembrane proteins contains three vertebrate members (LRIG1, LRIG2 and LRIG3) and one member each in flies (Lambik) and worms (Sma-10). LRIGs have stepped into the spotlight as essential regulators of growth factor receptors, including receptor tyrosine and serine/threonine kinases. LRIGs have been found to both negatively (LRIG1 and LRIG3) and positively (Sma-10 and LRIG3) regulate growth factor receptor expression and signaling, although the precise molecular mechanisms by which LRIGs function are not yet understood. The most is known about LRIG1, which was recently demonstrated to be a tumor suppressor. Indeed, in vivo experiments reinforce the essential link between LRIG1 and repression of its targets for tissue homeostasis. LRIG1 has also been identified as a stem cell marker and regulator of stem cell quiescence in a variety of tissues, discussed within. Comparably, less is known about LRIG2 and LRIG3, although studies to date suggest that their functions are largely distinct from that of LRIG1 and that they likely do not serve as growth/tumor suppressors. Finally, the translational applications of expressing soluble forms of LRIG1 in LRIG1-deficient tumors are being explored and hold tremendous promise.

Original languageEnglish (US)
Pages (from-to)R431-R443
JournalEndocrine-Related Cancer
Volume21
Issue number6
DOIs
StatePublished - Dec 1 2014

Fingerprint

Growth Factor Receptors
Leucine
Stem Cells
Neoplasms
Protein-Serine-Threonine Kinases
Diptera
Vertebrates
Homeostasis
Growth
Immunoglobulin Domains
Proteins

Keywords

  • Growth factor receptor
  • LRIG1
  • LRIG2
  • LRIG3
  • Stem cell
  • Tumor suppressor

ASJC Scopus subject areas

  • Endocrinology
  • Oncology
  • Cancer Research
  • Endocrinology, Diabetes and Metabolism

Cite this

The LRIG family : Enigmatic regulators of growth factor receptor signaling. / Simion, Catalina; Cedano-Prieto, Maria Elvira; Sweeney, Colleen A.

In: Endocrine-Related Cancer, Vol. 21, No. 6, 01.12.2014, p. R431-R443.

Research output: Contribution to journalArticle

Simion, Catalina ; Cedano-Prieto, Maria Elvira ; Sweeney, Colleen A. / The LRIG family : Enigmatic regulators of growth factor receptor signaling. In: Endocrine-Related Cancer. 2014 ; Vol. 21, No. 6. pp. R431-R443.
@article{7b1e24ffd0c9451f8becd0a1615479d2,
title = "The LRIG family: Enigmatic regulators of growth factor receptor signaling",
abstract = "The leucine-rich repeats and immunoglobulin-like domains (LRIG) family of transmembrane proteins contains three vertebrate members (LRIG1, LRIG2 and LRIG3) and one member each in flies (Lambik) and worms (Sma-10). LRIGs have stepped into the spotlight as essential regulators of growth factor receptors, including receptor tyrosine and serine/threonine kinases. LRIGs have been found to both negatively (LRIG1 and LRIG3) and positively (Sma-10 and LRIG3) regulate growth factor receptor expression and signaling, although the precise molecular mechanisms by which LRIGs function are not yet understood. The most is known about LRIG1, which was recently demonstrated to be a tumor suppressor. Indeed, in vivo experiments reinforce the essential link between LRIG1 and repression of its targets for tissue homeostasis. LRIG1 has also been identified as a stem cell marker and regulator of stem cell quiescence in a variety of tissues, discussed within. Comparably, less is known about LRIG2 and LRIG3, although studies to date suggest that their functions are largely distinct from that of LRIG1 and that they likely do not serve as growth/tumor suppressors. Finally, the translational applications of expressing soluble forms of LRIG1 in LRIG1-deficient tumors are being explored and hold tremendous promise.",
keywords = "Growth factor receptor, LRIG1, LRIG2, LRIG3, Stem cell, Tumor suppressor",
author = "Catalina Simion and Cedano-Prieto, {Maria Elvira} and Sweeney, {Colleen A}",
year = "2014",
month = "12",
day = "1",
doi = "10.1530/ERC-14-0179",
language = "English (US)",
volume = "21",
pages = "R431--R443",
journal = "Endocrine-Related Cancer",
issn = "1351-0088",
publisher = "Society for Endocrinology",
number = "6",

}

TY - JOUR

T1 - The LRIG family

T2 - Enigmatic regulators of growth factor receptor signaling

AU - Simion, Catalina

AU - Cedano-Prieto, Maria Elvira

AU - Sweeney, Colleen A

PY - 2014/12/1

Y1 - 2014/12/1

N2 - The leucine-rich repeats and immunoglobulin-like domains (LRIG) family of transmembrane proteins contains three vertebrate members (LRIG1, LRIG2 and LRIG3) and one member each in flies (Lambik) and worms (Sma-10). LRIGs have stepped into the spotlight as essential regulators of growth factor receptors, including receptor tyrosine and serine/threonine kinases. LRIGs have been found to both negatively (LRIG1 and LRIG3) and positively (Sma-10 and LRIG3) regulate growth factor receptor expression and signaling, although the precise molecular mechanisms by which LRIGs function are not yet understood. The most is known about LRIG1, which was recently demonstrated to be a tumor suppressor. Indeed, in vivo experiments reinforce the essential link between LRIG1 and repression of its targets for tissue homeostasis. LRIG1 has also been identified as a stem cell marker and regulator of stem cell quiescence in a variety of tissues, discussed within. Comparably, less is known about LRIG2 and LRIG3, although studies to date suggest that their functions are largely distinct from that of LRIG1 and that they likely do not serve as growth/tumor suppressors. Finally, the translational applications of expressing soluble forms of LRIG1 in LRIG1-deficient tumors are being explored and hold tremendous promise.

AB - The leucine-rich repeats and immunoglobulin-like domains (LRIG) family of transmembrane proteins contains three vertebrate members (LRIG1, LRIG2 and LRIG3) and one member each in flies (Lambik) and worms (Sma-10). LRIGs have stepped into the spotlight as essential regulators of growth factor receptors, including receptor tyrosine and serine/threonine kinases. LRIGs have been found to both negatively (LRIG1 and LRIG3) and positively (Sma-10 and LRIG3) regulate growth factor receptor expression and signaling, although the precise molecular mechanisms by which LRIGs function are not yet understood. The most is known about LRIG1, which was recently demonstrated to be a tumor suppressor. Indeed, in vivo experiments reinforce the essential link between LRIG1 and repression of its targets for tissue homeostasis. LRIG1 has also been identified as a stem cell marker and regulator of stem cell quiescence in a variety of tissues, discussed within. Comparably, less is known about LRIG2 and LRIG3, although studies to date suggest that their functions are largely distinct from that of LRIG1 and that they likely do not serve as growth/tumor suppressors. Finally, the translational applications of expressing soluble forms of LRIG1 in LRIG1-deficient tumors are being explored and hold tremendous promise.

KW - Growth factor receptor

KW - LRIG1

KW - LRIG2

KW - LRIG3

KW - Stem cell

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=84919639057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919639057&partnerID=8YFLogxK

U2 - 10.1530/ERC-14-0179

DO - 10.1530/ERC-14-0179

M3 - Article

VL - 21

SP - R431-R443

JO - Endocrine-Related Cancer

JF - Endocrine-Related Cancer

SN - 1351-0088

IS - 6

ER -